162 related articles for article (PubMed ID: 22698405)
21. Potential therapeutic applications of microRNAs in response to DNA damage in cancer stem cells.
Garg M
J Stem Cells; 2011; 6(2):51-65. PubMed ID: 22997846
[TBL] [Abstract][Full Text] [Related]
22. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow.
Gao J; Yang T; Han J; Yan K; Qiu X; Zhou Y; Fan Q; Ma B
J Cell Biochem; 2011 Jul; 112(7):1844-56. PubMed ID: 21416501
[TBL] [Abstract][Full Text] [Related]
24. α-Catulin knockdown induces senescence in cancer cells.
Fan LC; Chiang WF; Liang CH; Tsai YT; Wong TY; Chen KC; Hong TM; Chen YL
Oncogene; 2011 Jun; 30(23):2610-21. PubMed ID: 21278790
[TBL] [Abstract][Full Text] [Related]
25. Evidence for cancer stem cells in human endometrial carcinoma.
Hubbard SA; Friel AM; Kumar B; Zhang L; Rueda BR; Gargett CE
Cancer Res; 2009 Nov; 69(21):8241-8. PubMed ID: 19843861
[TBL] [Abstract][Full Text] [Related]
26. Embryonic stem cell-related miRNAs are involved in differentiation of pluripotent cells originating from the germ line.
Zovoilis A; Pantazi A; Smorag L; Opitz L; Riester GS; Wolf M; Zechner U; Holubowska A; Stewart CL; Engel W
Mol Hum Reprod; 2010 Nov; 16(11):793-803. PubMed ID: 20566704
[TBL] [Abstract][Full Text] [Related]
27. Identification of altered MicroRNA expression patterns in synovial sarcoma.
Hisaoka M; Matsuyama A; Nagao Y; Luan L; Kuroda T; Akiyama H; Kondo S; Hashimoto H
Genes Chromosomes Cancer; 2011 Mar; 50(3):137-45. PubMed ID: 21213367
[TBL] [Abstract][Full Text] [Related]
28. miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence.
Osaki M; Okada F; Ochiya T
Ther Deliv; 2015 Mar; 6(3):323-37. PubMed ID: 25853308
[TBL] [Abstract][Full Text] [Related]
29. A Cancer Reprogramming Method Using MicroRNAs as a Novel Therapeutic Approach against Colon Cancer: Research for Reprogramming of Cancer Cells by MicroRNAs.
Miyazaki S; Yamamoto H; Miyoshi N; Wu X; Ogawa H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Konno M; Doki Y; Mori M; Ishii H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1394-401. PubMed ID: 25384704
[TBL] [Abstract][Full Text] [Related]
30. Effect of Xenotransplantation Site on MicroRNA Expression of Human Colon Cancer Stem Cells.
Mukohyama J; Shimono Y; Yamashita K; Sumi Y; Mukohara T; Minami H; Kakeji Y
Anticancer Res; 2016 Jul; 36(7):3679-86. PubMed ID: 27354640
[TBL] [Abstract][Full Text] [Related]
31. Identification of cancer stem cell-related microRNAs in hepatocellular carcinoma.
Ji J; Wang XW
Methods Mol Biol; 2012; 826():163-75. PubMed ID: 22167648
[TBL] [Abstract][Full Text] [Related]
32. Emerging role of microRNAs in cancer and cancer stem cells.
Hao J; Zhao S; Zhang Y; Zhao Z; Ye R; Wen J; Li J
J Cell Biochem; 2014 Apr; 115(4):605-10. PubMed ID: 24166873
[TBL] [Abstract][Full Text] [Related]
33. miR-135a Inhibits Cancer Stem Cell-Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression.
Hemmesi K; Squadrito ML; Mestdagh P; Conti V; Cominelli M; Piras IS; Sergi LS; Piccinin S; Maestro R; Poliani PL; Speleman F; De Palma M; Galli R
Stem Cells; 2015 May; 33(5):1377-89. PubMed ID: 25639612
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
Leal JA; Lleonart ME
Cancer Lett; 2013 Sep; 338(1):174-83. PubMed ID: 22554710
[TBL] [Abstract][Full Text] [Related]
35. Identification of cancer stem cells in Ewing's sarcoma.
Suvà ML; Riggi N; Stehle JC; Baumer K; Tercier S; Joseph JM; Suvà D; Clément V; Provero P; Cironi L; Osterheld MC; Guillou L; Stamenkovic I
Cancer Res; 2009 Mar; 69(5):1776-81. PubMed ID: 19208848
[TBL] [Abstract][Full Text] [Related]
36. Functional Redundancy of DICER Cofactors TARBP2 and PRKRA During Murine Embryogenesis Does Not Involve miRNA Biogenesis.
Pullagura SRN; Buaas B; Gray N; Krening LC; Srivastava A; Braun RE
Genetics; 2018 Apr; 208(4):1513-1522. PubMed ID: 29467169
[TBL] [Abstract][Full Text] [Related]
37. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion.
Iliopoulos D; Hirsch HA; Wang G; Struhl K
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1397-402. PubMed ID: 21220315
[TBL] [Abstract][Full Text] [Related]
38. BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression.
Douglas D; Hsu JH; Hung L; Cooper A; Abdueva D; van Doorninck J; Peng G; Shimada H; Triche TJ; Lawlor ER
Cancer Res; 2008 Aug; 68(16):6507-15. PubMed ID: 18701473
[TBL] [Abstract][Full Text] [Related]
39. The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells.
Cieślar-Pobuda A; Jain MV; Kratz G; Rzeszowska-Wolny J; Ghavami S; Wiechec E
Oncotarget; 2015 Oct; 6(30):29753-70. PubMed ID: 26337471
[TBL] [Abstract][Full Text] [Related]
40. Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma.
Wei Q; Tang YJ; Voisin V; Sato S; Hirata M; Whetstone H; Han I; Ailles L; Bader GD; Wunder J; Alman BA
Oncotarget; 2015 Nov; 6(37):40283-94. PubMed ID: 26517673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
